Atibeprone is an investigational antidepressant, a coumarin derivative containing a thiadiazole moiety, that was developed in the mid-1990s but never marketed.
- Explored as a structurally novel antidepressant candidate outside the SSRI/SNRI/tricyclic families
Overview
One of many antidepressant candidates from the 1990s that quietly disappeared; almost nothing about its mechanism or trial results is publicly documented.
Mechanism
Publicly available sources do not describe a specific receptor or transporter mechanism for atibeprone. Its structural class, a coumarin and thiadiazole hybrid, is distinct from the SSRIs, SNRIs, and tricyclics that dominate the antidepressant field, but the pharmacological target responsible for its antidepressant activity has not been documented in accessible literature.
Safetyrisks and cautions, not medical advice
No safety, tolerability, or clinical trial data for atibeprone are publicly available. It does not have an assigned ATC code, consistent with a compound that was abandoned during early development.
Subjective profileweighing the evidence above
Nothing to judge here. A mid-1990s antidepressant candidate with no published efficacy or safety data and no assigned ATC code, which usually means it died quietly in early development. Of interest to compound historians and no one else.
Resources
This entry is here for reference.
Reviews
My notesprivate to this device
FAQ
What is Atibeprone used for?
It was developed as a candidate antidepressant in the mid-1990s but was never marketed and has no approved use.
How does Atibeprone work?
Its exact mechanism was never publicly documented; its chemical structure is a coumarin/thiadiazole hybrid unrelated to standard antidepressant classes.
Is Atibeprone well-researched?
No. Public information is limited to a brief pharmacological dictionary entry, with no accessible clinical trial data.
Limitations of the evidence
- No published human safety or efficacy data
- Never received an ATC code or reached the market
Notes and cautions
- Mechanism of action was never publicly documented